Filing Details
- Accession Number:
- 0001209191-17-012096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-17 16:22:19
- Reporting Period:
- 2017-02-15
- Filing Date:
- 2017-02-17
- Accepted Time:
- 2017-02-17 16:22:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1173489 | Ceva Inc | CEVA | Semiconductors & Related Devices (3674) | 770556376 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1200368 | Issachar Ohana | Ceva, Inc. 1174 Castro Street, Suite 210 Mountain View CA 94040 | Evp Worldwide Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-02-15 | 1,875 | $15.54 | 36,968 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-02-15 | 827 | $35.25 | 36,141 | No | 4 | D | Direct | |
Common Stock | Disposition | 2017-02-15 | 1,048 | $35.25 | 35,093 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Right | Disposition | 2017-02-15 | 1,875 | $0.00 | 1,875 | $15.54 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-07-31 | No | 4 | M | Direct |
Footnotes
- The Stock Appreciation Rights became exercisable as to 25% of the underlying shares on the first anniversary of the grant date and 1/48th of underlying shares each month thereafter.